Crinetics Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 14.29 M | $665.38 M | 0.75% | 15.17% |
| VANGUARD GROUP INC | 01/29/2026 | 9.14 M | $425.26 M | -0.38% | 9.70% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 8.04 M | $374.16 M | -4.11% | 8.53% |
| BLACKROCK, INC. | 02/12/2026 | 7.99 M | $371.87 M | 5.30% | 8.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 6.93 M | $322.74 M | 20.16% | 7.36% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 6.39 M | $297.35 M | -1.45% | 6.78% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 5.22 M | $243.20 M | -1.54% | 5.55% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.44 M | $206.60 M | 15.08% | 4.71% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 4.29 M | $199.61 M | 0.00% | 4.55% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 2.34 M | $108.79 M | 16.66% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.24 M | $104.41 M | -1.59% | 2.38% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 2.21 M | $102.91 M | -13.33% | 2.35% |
| STATE STREET CORP | 02/13/2026 | 2.16 M | $100.61 M | -2.10% | 2.29% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 1.65 M | $76.75 M | 488.88% | 1.75% |
| NOVO HOLDINGS A/S | 02/17/2026 | 1.63 M | $75.64 M | 0.00% | 1.72% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.56 M | $72.63 M | 6.49% | 1.66% |
| SIREN, L.L.C. | 02/13/2026 | 1.51 M | $70.18 M | -10.72% | 1.60% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.48 M | $68.72 M | 73.57% | 1.57% |
| RTW INVESTMENTS, LP | 02/17/2026 | 1.35 M | $62.90 M | 54.90% | 1.43% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.33 M | $61.79 M | 59.15% | 1.41% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 1.28 M | $59.66 M | -37.32% | 1.36% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 1.19 M | $55.59 M | 26.84% | 1.27% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.15 M | $53.75 M | -8.26% | 1.23% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.07 M | $49.76 M | -5.70% | 1.13% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 999.00 K | $46.50 M | -9.10% | 1.06% |
| UBS GROUP AG | 01/29/2026 | 908.19 K | $42.28 M | 122.75% | 0.96% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 897.40 K | $41.77 M | 1.63% | 0.95% |
| CANDRIAM S.C.A. | 04/30/2026 | 830.96 K | $38.68 M | 11.52% | 0.88% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 801.31 K | $37.30 M | 33.32% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 781.98 K | $36.40 M | 0.43% | 0.83% |
| NORTHERN TRUST CORP | 02/17/2026 | 769.82 K | $35.84 M | -4.95% | 0.82% |
| MORGAN STANLEY | 02/13/2026 | 768.83 K | $35.79 M | 12.71% | 0.82% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 758.66 K | $35.32 M | 0.04% | 0.81% |
| ABRDN PLC | 01/16/2026 | 674.53 K | $31.40 M | 98.42% | 0.72% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 601.19 K | $27.99 M | -2.22% | 0.64% |
| FIERA CAPITAL CORP | 02/11/2026 | 578.46 K | $26.93 M | 32.85% | 0.61% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 567.13 K | $26.40 M | -20.47% | 0.60% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 548.98 K | $25.56 M | 45.31% | 0.58% |
| NUVEEN, LLC | 02/12/2026 | 522.47 K | $24.32 M | -4.09% | 0.55% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 01/28/2026 | 408.31 K | $19.01 M | 5.26% | 0.43% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 405.01 K | $18.85 M | 1.35% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 398.40 K | $18.55 M | 63.35% | 0.42% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 368.50 K | $17.15 M | 100.00% | 0.39% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 309.37 K | $14.40 M | 24.56% | 0.33% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 302.00 K | $14.06 M | 770.47% | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 300.34 K | $13.98 M | 38.89% | 0.32% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 300.00 K | $13.97 M | -25.00% | 0.32% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 275.62 K | $12.83 M | -6.57% | 0.29% |
| IMPAX ASSET MANAGEMENT GROUP PLC | 01/29/2026 | 275.00 K | $12.80 M | 100.00% | 0.29% |
| PROSIGHT MANAGEMENT, LP | 02/13/2026 | 262.90 K | $12.24 M | -20.01% | 0.28% |
Crinetics Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 315 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals Inc. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 1.88 M
JENNISON ASSOCIATES LLC: 904,672
DIMENSIONAL FUND ADVISORS LP: 852,258
Candriam S.C.A.: 830,961
abrdn plc: 820,395
Fisher Asset Management, LLC: 762,702
118.46% of Crinetics Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 121.41 M shares in the last 24 months. This purchase volume represents approximately $4.64 B in transactions.